Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 20/20 | 0.65 |
| ▸ | PIK3CA | P42336 | 20/20 | 0.65 |
| ▸ | PIK3R1 | P27986 | 19/20 | 0.65 |
| ▸ | PIK3CB | P42338 | 14/20 | 0.51 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17011983 | 0.89 | PIK3CD (0.83) | PIK3CDPIK3CAPIK3R1PIK3CB | |
| SCHEMBL477221 | 0.79 | PIK3CD (1.00) | PIK3CDPIK3CAPIK3R1PIK3CB | |
| SCHEMBL374947 | 0.69 | PIK3CB (1.00) | PIK3CDPIK3CAPIK3R1PIK3CBPIK3CG | |
| SCHEMBL12789917 | 0.68 | PIK3CD (0.69) | PIK3CDPIK3CAPIK3R1PIK3CB | |
| SCHEMBL12789920 | 0.68 | PIK3CD (0.69) | PIK3CDPIK3CAPIK3R1PIK3CB | |
| SCHEMBL477689 | 0.68 | PIK3CD (1.00) | PIK3CDPIK3CAPIK3R1PIK3CB | |
| SCHEMBL2956569 | 0.67 | PIK3CB (0.77) | PIK3CDPIK3CAPIK3R1PIK3CBPIK3CG | |
| SCHEMBL477387 | 0.67 | PIK3CD (0.84) | PIK3CDPIK3CAPIK3R1PIK3CB | |
| SCHEMBL2958351 | 0.67 | PIK3CB (0.80) | PIK3CDPIK3CAPIK3R1PIK3CBPIK3CG | |
| SCHEMBL2950686 | 0.67 | PIK3CB (0.76) | PIK3CDPIK3CAPIK3R1PIK3CBPIK3CG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010110685-A2 | PYRIMDDINYL AND 1,3,5-TRIAZINYL BENZIMTOAZOLE SULFONAMIDES AND THEIR USE IN CANCER THERAPY | PATHWAY THERAPEUTICS LIMITED (NZ) | 2010-09-30 | — | — | WO | disclosed |